We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Towne Bank
TOWN
$3.46B
| $2.26M | 0.01% |
69,747
+3,554
| +5% | +$115K |
|
|
CVA
1477
DELISTED
Covanta Holding Corporation
CVA
| $2.25M | 0.01% |
143,184
+5,476
| +4% | +$86K |
|
1478
IMAX
IMAX
$2.62B
| $2.25M | 0.01% |
66,098
+2,702
| +4% | +$88.1K |
|
|
VTLE
1479
DELISTED
Vital Energy
VTLE
| $2.25M | 0.01% |
7,695
+812
| +12% | +$226K |
|
|
TSE
1480
DELISTED
Trinseo
TSE
| $2.24M | 0.01% |
33,374
+327
| +1% | +$22K |
|
|
ALOG
1481
DELISTED
Analogic Corp
ALOG
| $2.24M | 0.01% |
29,482
+6,887
| +30% | +$540K |
|
1482
CareTrust REIT
CTRE
$9.91B
| $2.24M | 0.01% |
132,919
+45,592
| +52% | +$708K |
|
|
KW
1483
DELISTED
Kennedy-Wilson Holdings
KW
| $2.23M | 0.01% |
100,473
+2,462
| +3% | +$51.8K |
|
1484
Invesco Mortgage Capital
IVR
$759M
| $2.23M | 0.01% |
14,460
+510
| +4% | +$77K |
|
|
SONC
1485
DELISTED
Sonic Corp
SONC
| $2.22M | 0.01% |
87,699
+24,183
| +38% | +$610K |
|
|
SYNH
1486
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.22M | 0.01% |
48,321
+2,949
| +6% | +$147K |
|
|
ICPT
1487
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.21M | 0.01% |
19,531
-25
| -0.1% | -$2.92K |
|
1488
Zurn Elkay Water Solutions
ZWS
$8.38B
| $2.21M | 0.01% |
198,625
+7,762
| +4% | +$83.6K |
|
1489
Safety Insurance
SAFT
$1.52B
| $2.2M | 0.01% |
31,325
+8,404
| +37% | +$603K |
|
1490
Andersons Inc
ANDE
$2.41B
| $2.19M | 0.01% |
57,876
+13,624
| +31% | +$526K |
|
1491
Dillards
DDS
$9.19B
| $2.19M | 0.01% |
41,882
+22,481
| +116% | +$1.23M |
|
|
RP
1492
DELISTED
RealPage, Inc.
RP
| $2.18M | 0.01% |
62,449
+2,479
| +4% | +$80.9K |
|
|
WLL
1493
DELISTED
Whiting Petroleum Corporation
WLL
| $2.18M | 0.01% |
767
+107
| +16% | +$346K |
|
|
MRC
1494
DELISTED
MRC Global
MRC
| $2.18M | 0.01% |
118,717
+5,362
| +5% | +$106K |
|
|
EXTN
1495
DELISTED
Exterran Corporation
EXTN
| $2.18M | 0.01% |
69,188
+17,735
| +34% | +$531K |
|
|
SNBR
1496
DELISTED
Sleep Number
SNBR
| $2.17M | 0.01% |
87,644
+20,940
| +31% | +$469K |
|
|
WIRE
1497
DELISTED
Encore Wire Corp
WIRE
| $2.17M | 0.01% |
47,249
+10,497
| +29% | +$469K |
|
1498
Scansource
SCSC
$1.15B
| $2.17M | 0.01% |
55,299
+13,853
| +33% | +$565K |
|
1499
Innoviva
INVA
$1.55B
| $2.17M | 0.01% |
156,788
+44,662
| +40% | +$526K |
|
1500
Ambarella
AMBA
$3.77B
| $2.17M | 0.01% |
39,612
+1,187
| +3% | +$64.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.